Victoria urged to act on coroner's death in custody recommendations
NOTE: This story uses images of Heather Calgaret with the permission of her family.
On Monday, Coroner Sarah Gebert found the 30-year-old's death due to respiratory failure was the result of an inappropriately prescribed dose of an opioid medication.
The coroner also found that in the lead-up to Heather's death, the Yamatji, Noongar, Wongi and Pitjantjatjara woman's mental and physical health had declined significantly.
After identifying gaps in the health care that was available to Heather, the coroner recommended the government do more to integrate Aboriginal health groups in the delivery of prison health care.
Aunty Jill Gallagher, who heads up the Victorian Aboriginal Community-Controlled Healthcare Organisation (VACCHO), said the benefits of Aboriginal-led health responses for Indigenous communities were clear.
"We know who the people are, we know their families, we know their issues," she said.
"We have wraparound services … that we could provide to our people in prisons … and it also helps to get them, when they are released, back into society."
Ms Gallagher said before the recent state budget, her organisation had sought $2 million in funding to support a pilot program where Aboriginal health groups could deliver care in prison.
"It was knocked back, we didn't get the $2 million to deliver that model," she said.
She said the request came against the backdrop of more than $720 million being allocated in the same budget to boost the number of prison beds.
Ms Gallagher said the proposal to integrate Aboriginal-led health responses had been a recommendation in a recent report into Victoria's prisons she co-authored.
"Where's the implementation of those recommendations in that report?" she asked.
In her findings, the coroner also explored issues with the way Heather's parole application had been dealt with.
The inquest heard a "Kafkian" situation meant Heather could not get access to a rehabilitation program that was a requirement for her to be eligible for parole.
Ms Gebert said the inquest had identified "numerous" other issues with the way Heather's parole application was managed, including poor documentation by parole officers and a "lack of adherence to relevant metrics".
She said of particular concern was the lack of appropriate action in response to a letter Heather had written asking to undertake the rehabilitative program in the community.
The coroner recommended changes to ensure parole officers were more responsive to requests and maintained better documentation.
In a statement, Victorian Aboriginal Legal Service (VALS) acting CEO Amanda Dunstall said the Allan government's current "tough on crime approach" involved an "abhorrent commitment to implementing regressive laws" at odds with the coroner's recommendations.
"Victoria's parole process was found to be unfair to Aboriginal women, and is inconsistent with the right to equality in the charter and the right to Aboriginal self-determination," she said.
"We know that sentencing and parole considerations for Aboriginal people are of critical importance and VALS is ready to work with the Department of Corrections, alongside the Aboriginal Justice Caucus, to implement these recommendations immediately, alongside the outstanding recommendations from the Royal Commission into Aboriginal Deaths in Custody and the Yoorrook Justice Commission."
Corrections Minister Enver Erdogan was contacted for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
43 minutes ago
- News.com.au
Labor vows to ‘fight' as Trump threatens pharma tariffs
The Albanese government is vowing to 'fight for the PBS' as Donald Trump tries to strongarm drugmakers into moving production to the US. The Pharmaceutical Benefits Scheme (PBS) is a list of federally subsidised medicines and a prized Labor invention. Health Minister Mark Butler last month introduced legislation that, if passed, would cap PBS-listed medicines at $25 from January 1, 2026. Aside from subsidising medicines, the scheme also compels firms to negotiate prices with the federal government, which helps keep products affordable. Celebrated as a cornerstone of the healthcare system in Canberra, the scheme is denounced by pharmaceutical lobbyists in Washington, who claim Australia is 'freeloading on American innovation'. One group, Pharmaceutical Research and Manufacturers of America (PhRMA), has explicitly urged the Trump administration to 'leverage ongoing trade negotiations' to influence Australia's PBS policies. But Anthony Albanese, Mr Butler and other ministers have ruled out budging on the PBS. 'We'll fight for our PBS and fight for the jobs of Australian manufacturers here,' Mr Butler told the ABC on Friday, noting most production is in Melbourne. Pharmaceutical exports to the US totalled north of $2bn in 2024, making it the biggest foreign market for Australian producers. Exports are mostly blood products and vaccines but also include packaged medicines and miscellaneous medical items, such as bandages. Though, as Mr Butler noted, the US still exported more to Australia and did so without tariffs. 'We have zero tariffs on those imports that we take from America companies,' he said. 'We're making the case that should continue in reverse. 'We should be able to continue to export our terrific blood and plasma products and medicines to Americans without what might be a 250 per cent tariff.' For the moment, Mr Trump's concern with the sector appears to be largely driven by bringing down prices in the US rather than punishing allies for having cheaper medicines. Last week, he wrote to 17 major pharmaceutical companies demanding they lower their prices for American consumers to bring them in line with prices overseas. A Rand Corporation report found that Americans pay nearly four times more than Australians for medicines and about three times more than the average in other developed economies. The answer, according to Mr Trump, is making pharmaceuticals in the US. Mr Trump's 250 per cent tariff threat was a warning shot to firms, but one that, if realised, would hit producers Down Under hard.
ABC News
2 hours ago
- ABC News
Brahman pioneer with Q fever saved by cow tissue heart valves
West Australian cattle pioneer Kathy Lovelock is known by the affectionate nickname "the Brahman lady". But the moniker took on a deeper significance a decade ago, when she had parts of her heart replaced with valves made from cattle tissue, in an effort to treat the effects of Q fever. Ms Lovelock, 80, has devoted most of her life to the cattle industry and has been instrumental in developing the Brahman breed across WA's Kimberley and Pilbara regions. Together with her husband, David Lovelock, she founded Canterbury Brahman Stud in 1972 at New Norcia, a town about 130 kilometres north of Perth. In 2015, they both underwent open-heart surgery to address complications from Q fever infections they had contracted many years before. The disease had caused blockages in their heart valves and, in a twist of fate, cow tissue played an essential role in their treatment. Replacement aortic valves are usually sourced from pig heart tissue, but Ms Lovelock is allergic to pigs, so she and her surgeon were left with no choice but to find an alternative. Ms Lovelock said she believed it was tissue from Brahman cattle that saved her life. "[The surgeon] actually went to California to source a bovine aortic valve, and informed us the tissue for that valve came from cattle in Brisbane," she said. "The way we look at it is Queensland is dominated by Brahman cattle, so if they came from Brisbane or Queensland, it had to be Brahman tissue. "There's a fair chance, in our opinion." Ms Lovelock insisted it was pure coincidence that the cattle she had dedicated her life to breeding ultimately saved it. Although not allergic to pigs, Mr Lovelock also received replacement aortic valves made using bovine tissue from Queensland cattle. They understood that aortic valves sourced from cattle heart tissue would last longer than the pig equivalent. Ms Lovelock said she and her husband contracted Q fever in 1995 while visiting sheep and goat sheds in Sabah, a state of East Malaysia on the island of Borneo. "They thought I had dengue fever because there was no diagnosis for Q fever at the time." Her symptoms included lethargy, a fever and headaches; she said it was like a serious case of the flu. The cause was not identified as Q fever until 2007. Nearly 20 years after contracting the disease and 10 years after undergoing open-heart surgery, Ms Lovelock is again facing challenges. She said her immune system was compromised and her heart valves were "playing up". Having another operation to replace her heart valves is not an option, so she is instead focused on managing her symptoms. Mr Lovelock, on the other hand, is doing "fine" — a contrast Ms Lovelock attributes to taking antibiotics she was allergic to. Q fever spreads when people inhale air or dust contaminated with Coxiella burnetii bacteria from the faeces or birth products of infected animals, and is usually associated with the livestock industry. Ms Lovelock is now urging others in the industry to get tested for Q fever and to get vaccinated if they have not been infected. In July, Ms Lovelock was inducted into the Royal Agricultural Society of WA Hall of Fame for her dedication to and impact on the West Australian cattle industry. She said it came as a total surprise. "It's great to have that recognition," Ms Lovelock said. Looking back over the past 50 years, Ms Lovelock said she was most proud to have the support of her husband and the industry as she worked to progress the Brahman breed. The farming matriarch has been actively involved in the Australian Brahman Breeders Association at both state and national levels, as well as the Cattle Council of Australia, and has made it a priority to inspire young people's interest in the beef industry.
News.com.au
2 hours ago
- News.com.au
Girl, 6, dies after being discharged from Sydney Children's Hospital twice in one day
A six-year-old girl has died after she was discharged from Sydney Children's Hospital twice in one day. The girl was brought to the Randwick hospital on Monday, where she was assessed and discharged. She was brought back a short time later and was admitted again, and diagnosed with influenza. She was discharged with instructions for 'at-home guidance', a Sydney Children's Hospital Network (SCHN) spokesperson confirmed. The girl was then taken to Northern Beaches Hospital, where she later died. A Sydney Children's Hospital Network spokesperson confirmed the course of events. 'SCHN has learnt the patient later tragically died,' they said. 'The SCHN expresses our deepest condolences to the family for the loss of their child.' They said the network was progressing an initial review into the care of the patient. A Northern Beaches Hospital spokesman said they were 'deeply saddened' by the loss of the child. 'Our heartfelt condolences go out to the child's family and loved ones during this incredibly difficult time,' the spokesman said. 'Alongside Sydney Children's Hospital Network, where the child received care earlier in the day, we will undertake the appropriate investigations in line with NSW Health policy, including a joint independent review. 'A coronial inquest has also been called into the child's passing. 'While we cannot comment on the specifics of the case during the review period, our thoughts are with the family, and we will continue to offer them our full support.' NSW Police said they were aware of the girl's death and a brief was being prepared for the coroner.
